Prostate Cancer: Former US President Joe Biden has been diagnosed with terminal cancer, his office announced on Sunday. The cancer has already spread to his bones. Biden, who has been suffering from urinary problems, was diagnosed with a tumor in his prostate gland after undergoing medical tests. His family is currently exploring options for treatment, it said. “Although this is a serious cancer, hormone therapy has the potential to reduce the risk of recurrence. Therefore, the former president and his family are exploring treatment options with the advice of their doctors,” the statement explained. Joe Biden withdrew from the US presidential race last year due to health reasons.
In this context, let’s delve deeper into the details regarding the terminal cancer diagnosis that President Biden is currently facing:
It is one of the most common cancers affecting men, especially those over the age of 65. It develops in the prostate, a small gland responsible for producing seminal fluid. While many prostate cancers grow slowly and remain localized, some can be aggressive and spread quickly. In the early stages, this cancer often presents no symptoms. As the disease progresses, signs may include difficulty urinating, blood in urine or semen, pelvic discomfort, or bone pain.
Diagnosis typically involves a PSA (prostate-specific antigen) blood test, a digital rectal exam, and sometimes a biopsy. Treatment options depend on the stage and aggressiveness of the cancer and may include surgery, radiation therapy, hormone therapy, and, in advanced cases, chemotherapy or palliative care. While survival rates are high for localized prostate cancer, outcomes significantly worsen if the cancer spreads to other organs. Raising public awareness is crucial for early detection and timely intervention.
Prostate cancer can vary significantly in severity, ranging from low-risk to life-threatening, depending on how early it is detected and how aggressive it is. In most cases, particularly when diagnosed early, prostate cancer grows slowly and is highly treatable; the 5-year survival rate for localized prostate cancer exceeds 99%.
In contrast, advanced or metastatic prostate cancer, which occurs when the cancer has spread to other parts of the body (such as bones or lymph nodes), is much more serious. The 5-year survival rate for metastatic cases drops to around 30%. Many men can live for years with this cancer, especially with the advent of newer treatments. However, in its terminal stages, prostate cancer can be deadly and may lead to complications such as severe bone pain, urinary obstruction, and organ failure.
Therefore, while early-stage prostate cancer is often manageable, advanced cases can be life-threatening. This underscores the importance of regular screening and early detection.
Also Read: Why America Still Has No Bullet Trains: Here’s Why
Share
Rupee Strengthens Against US Dollar: Key Factors Behind Rise
ED Arrests Ex-UCO Bank CMD Goel in Money Laundering Case
